Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-056229

Director acquired 10,288 shares (option exercise)

  • Director gave 10,288 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TARNOW MICHAEL M Director 2020-10-28 Option exercise +5,144 $3.76 $19,341 74,857 D: show line 1 in the form
TARNOW MICHAEL M Director 2020-10-28 Option exercise +5,144 $3.76 $19,341 80,001 D: show line 2 in the form
TARNOW MICHAEL M Director 2020-10-28 Gift −10,288 69,713 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
TARNOW MICHAEL M Director 2020-10-28 Option exercise · Stock Option (Right to Buy) −5,144 0 D: show line 4 in the form
TARNOW MICHAEL M Director 2020-10-28 Option exercise · Stock Option (Right to Buy) −5,144 0 D: show line 5 in the form
Loading xslF345X03/doc4.xml…